News & Updates

The fatty acid synthase inhibitor denifanstat shows potential for treating moderate-to-severe acne vulgaris, with good safety and tolerability, as demonstrated in a study from China presented at EADV 2025.

A US cohort study of schools matched to child and adolescent patient medical records from a network of community health organizations found an association between school participation in the Community Eligibility Provision (CEP) programme and a net reduction in blood pressure (BP) outcomes.